EP3077549A4 - Signatures géniques pour pronostiquer un cancer du rein - Google Patents
Signatures géniques pour pronostiquer un cancer du rein Download PDFInfo
- Publication number
- EP3077549A4 EP3077549A4 EP14868575.3A EP14868575A EP3077549A4 EP 3077549 A4 EP3077549 A4 EP 3077549A4 EP 14868575 A EP14868575 A EP 14868575A EP 3077549 A4 EP3077549 A4 EP 3077549A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- renal cancer
- cancer prognosis
- gene signatures
- signatures
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361911926P | 2013-12-04 | 2013-12-04 | |
PCT/US2014/068628 WO2015085095A1 (fr) | 2013-12-04 | 2014-12-04 | Signatures géniques pour pronostiquer un cancer du rein |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3077549A1 EP3077549A1 (fr) | 2016-10-12 |
EP3077549A4 true EP3077549A4 (fr) | 2017-07-19 |
Family
ID=53274131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14868575.3A Withdrawn EP3077549A4 (fr) | 2013-12-04 | 2014-12-04 | Signatures géniques pour pronostiquer un cancer du rein |
Country Status (4)
Country | Link |
---|---|
US (1) | US20160281177A1 (fr) |
EP (1) | EP3077549A4 (fr) |
CA (1) | CA2930972A1 (fr) |
WO (1) | WO2015085095A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017193062A1 (fr) * | 2016-05-06 | 2017-11-09 | Myriad Genetics, Inc. | Signatures génétiques utilisées en vue du pronostic de cancer rénal |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010080933A1 (fr) * | 2009-01-07 | 2010-07-15 | Myriad Genetics, Inc | Biomarqueurs de cancer |
EP2404998A2 (fr) * | 2005-09-02 | 2012-01-11 | Kyoto University | Composition et procédé pour le diagnostic du cancer du rein et pour prédire le pronostic d'un patient atteint de cancer du rein |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080275652A1 (en) * | 2005-05-13 | 2008-11-06 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
US20120041274A1 (en) * | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
CA2826657A1 (fr) * | 2011-02-04 | 2012-08-09 | Bioarray Therapeutics, Inc. | Procedes d'utilisation de signatures d'expression genique pour selectionner un procede de traitement, predire un pronostic, la survie, et/ou predire une reponse a un traitement |
-
2014
- 2014-12-04 CA CA2930972A patent/CA2930972A1/fr not_active Abandoned
- 2014-12-04 EP EP14868575.3A patent/EP3077549A4/fr not_active Withdrawn
- 2014-12-04 WO PCT/US2014/068628 patent/WO2015085095A1/fr active Application Filing
-
2016
- 2016-06-02 US US15/171,993 patent/US20160281177A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2404998A2 (fr) * | 2005-09-02 | 2012-01-11 | Kyoto University | Composition et procédé pour le diagnostic du cancer du rein et pour prédire le pronostic d'un patient atteint de cancer du rein |
WO2010080933A1 (fr) * | 2009-01-07 | 2010-07-15 | Myriad Genetics, Inc | Biomarqueurs de cancer |
Non-Patent Citations (4)
Title |
---|
ANONYMOUS: "Expression of the PTTG1 Oncogene Is Associated with Aggressive Clear Cell Renal Cell Carcinoma | Cancer Research", 1 September 2012 (2012-09-01), XP055379452, Retrieved from the Internet <URL:http://cancerres.aacrjournals.org/content/72/17/4361.full-text.pdf> [retrieved on 20170608] * |
See also references of WO2015085095A1 * |
Y. DING ET AL: "Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets", CANCER RESEARCH, vol. 71, no. 15, 3 June 2011 (2011-06-03), & 104TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH (AACR); WASHINGTON, DC, USA; APRIL 06 -10, 2013, pages 5225 - 5234, XP055379455, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-11-0076 * |
ZHANG GUOJUN ET AL: "Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.", TUMOUR BIOLOGY : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR ONCODEVELOPMENTAL BIOLOGY AND MEDICINE JUN 2013, vol. 34, no. 3, June 2013 (2013-06-01), pages 1887 - 1894, XP002770937, ISSN: 1423-0380 * |
Also Published As
Publication number | Publication date |
---|---|
EP3077549A1 (fr) | 2016-10-12 |
US20160281177A1 (en) | 2016-09-29 |
WO2015085095A1 (fr) | 2015-06-11 |
CA2930972A1 (fr) | 2015-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1217218A1 (zh) | 結直腸癌生物標誌物 | |
EP3024948A4 (fr) | Dosages génétiques | |
EP2591126A4 (fr) | Signatures génétiques utilisées pour le pronostic du cancer | |
EP3003316A4 (fr) | Thérapies combinées contre le cancer | |
EP3095055A4 (fr) | Signature génomique obtenue à partir d'une biopsie pour pronostiquer un cancer de la prostate | |
EP2970543A4 (fr) | Ligands alkyl-acides pour nanocristaux | |
EP2994545A4 (fr) | Biomarqueurs de méthylation de l'adn pour le cancer de la vessie | |
EP2986326A4 (fr) | Méthodes de détection de métastases cancéreuses | |
EP2831270B8 (fr) | Biomarqueur pour cancer de la vessie | |
EP2977760A4 (fr) | Biomarqueur pour le diagnostic du cancer du foie | |
EP3047040A4 (fr) | Dosage multigénique pour le pronostic du cancer du rein | |
EP3077542A4 (fr) | Méthodes d'identification de composés antinéoplasiques | |
EP3245298A4 (fr) | Biomarqueurs de maladies liées au cancer colorectal | |
EP2985605A4 (fr) | Méthode de détection du cancer du colon | |
EP3007074A4 (fr) | Système de traitement d'informations | |
IL227419A0 (en) | Symptomatic signature for colon cancer recurrence | |
EP3036712A4 (fr) | Méthodes de prévision de pronostic | |
EP3058101A4 (fr) | Des micro-arn de sérum pour le pronostic du cancer de la prostate | |
EP2958999A4 (fr) | Signatures géniques pour le pronostic et le choix d'une thérapie pour le cancer du poumon | |
EP3030906A4 (fr) | Biomarqueurs pour le cancer de l'ovaire | |
EP2972376A4 (fr) | Procédés de détermination du pronostic du cancer colorectal | |
WO2012167112A9 (fr) | Marqueurs biologiques du cancer gastrique | |
EP3047039A4 (fr) | Inhibition de métastases cancéreuses | |
EP3250708A4 (fr) | Biomarqueurs pour maladies liées à un cancer colorectal | |
EP3015476A4 (fr) | Biomarqueur tumoral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160704 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170620 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/574 20060101ALI20170612BHEP Ipc: C12Q 1/68 20060101AFI20170612BHEP |
|
17Q | First examination report despatched |
Effective date: 20180612 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20191129 |